In CVD, the activation of Nrf2 can protect vascular tissue from OS damage and significantly attenuate cardiac arrhythmia, cardiac hypertrophy, and myocardial fibrosis. The gene discussed is NFE2L2; the disease is chronic obstructive pulmonary disease.